4//SEC Filing
YERXA BENJAMIN R 4
Accession 0001181431-10-020214
CIK 0001040416other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 5:25 PM ET
Size
10.6 KB
Accession
0001181431-10-020214
Insider Transaction Report
Form 4
YERXA BENJAMIN R
EVP & Chf, Research & Develop
Transactions
- Sale
Common Stock
2010-04-01$6.33/sh−721$4,564→ 55,536 total - Sale
Common Stock
2010-04-01$6.30/sh−300$1,890→ 54,776 total - Sale
Common Stock
2010-04-01$6.31/sh−260$1,641→ 55,076 total - Sale
Common Stock
2010-04-01$6.25/sh−519$3,244→ 54,257 total - Sale
Common Stock
2010-04-01$6.32/sh−200$1,264→ 55,336 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Sales Plan Agreement adopted by the Reporting Person on June 3, 2009.
Documents
Issuer
INSPIRE PHARMACEUTICALS INC
CIK 0001040416
Entity typeother
Related Parties
1- filerCIK 0001145910
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 5:25 PM ET
- Size
- 10.6 KB